“I don’t trust the FDA anymore”
World of DTC Marketing
JUNE 17, 2021
SKIMMERS SUMMARY: Health experts, including those on an external advisory committee to the FDA, are skeptical that Biogen’s drug will even successfully slow the progression of Alzheimer’s after late-stage clinical trials yielded mixed results and are angry the FDA approved the product. Medpage Today.
Let's personalize your content